Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Wilson

Showing results (191-200 of 219) with videos related to

Pageof 22
Sort By:
Trials|December 20, 2012
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trialGuy Thwaites, Cressida Auckland, Gavin Barlow, et al.
Circulation. Heart Failure|August 10, 2017
Progenitor Cells and Clinical Outcomes in Patients With Heart FailureAyman Samman Tahhan, Muhammad Hammadah, Pratik B Sandesara, et al.
International Journal of Cardiology|October 21, 2022
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registryJeremie Abtan, Deepak L Bhatt, Yedid Elbez, et al.
The American Journal of Cardiology|April 10, 2018
Comparison of the Association Between High-Sensitivity Troponin I and Adverse Cardiovascular Outcomes in Patients With Versus Without Chronic Kidney DiseasePratik B Sandesara, Wesley T O'Neal, Ayman Samman Tahhan, et al.
Journal of the Intensive Care Society|October 16, 2023
biomArker-guided Duration of Antibiotic treatment in hospitalised Patients with suspecTed Sepsis (ADAPT-Sepsis): A protocol for a multicentre randomised controlled trialPaul Dark, Gavin D Perkins, Ronan McMullan, et al.
Environmental Toxicology and Chemistry|October 26, 2018
An International Perspective on the Tools and Concepts for Effluent Toxicity Assessments in the Context of Animal Alternatives: Reduction in Vertebrate UseTeresa J Norberg-King, Michelle R Embry, Scott E Belanger, et al.
The American Journal of Cardiology|July 30, 2023
Aggregate Clinical and Biomarker-Based Model Predicts Adverse Outcomes in Patients With Coronary Artery DiseaseShivang R Desai, Devinder S Dhindsa, Yi-An Ko, et al.
JAMA Cardiology|August 10, 2018
Association of Interleukin 6 Receptor Variant With Cardiovascular Disease Effects of Interleukin 6 Receptor Blocking Therapy: A Phenome-Wide Association StudyTianxi Cai, Yichi Zhang, Yuk-Lam Ho, et al.
BMJ Quality & Safety|October 5, 2025
Understanding factors influencing sustainability and sustainment of evidence-based bronchiolitis management of infants in Australian and New Zealand hospital settings: a qualitative process evaluationVictoria Ramsden, Franz E Babl, Libby Haskell, et al.
Plos One|October 11, 2012
qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profilesSarah Song, Katia Nones, David Miller, et al.
Pageof 22

Showing results (191-200 of 219) with videos related to

Sort By:
Pageof 22
Trials|December 20, 2012
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trialGuy Thwaites, Cressida Auckland, Gavin Barlow, et al.
Circulation. Heart Failure|August 10, 2017
Progenitor Cells and Clinical Outcomes in Patients With Heart FailureAyman Samman Tahhan, Muhammad Hammadah, Pratik B Sandesara, et al.
International Journal of Cardiology|October 21, 2022
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registryJeremie Abtan, Deepak L Bhatt, Yedid Elbez, et al.
The American Journal of Cardiology|April 10, 2018
Comparison of the Association Between High-Sensitivity Troponin I and Adverse Cardiovascular Outcomes in Patients With Versus Without Chronic Kidney DiseasePratik B Sandesara, Wesley T O'Neal, Ayman Samman Tahhan, et al.
Journal of the Intensive Care Society|October 16, 2023
biomArker-guided Duration of Antibiotic treatment in hospitalised Patients with suspecTed Sepsis (ADAPT-Sepsis): A protocol for a multicentre randomised controlled trialPaul Dark, Gavin D Perkins, Ronan McMullan, et al.
Environmental Toxicology and Chemistry|October 26, 2018
An International Perspective on the Tools and Concepts for Effluent Toxicity Assessments in the Context of Animal Alternatives: Reduction in Vertebrate UseTeresa J Norberg-King, Michelle R Embry, Scott E Belanger, et al.
The American Journal of Cardiology|July 30, 2023
Aggregate Clinical and Biomarker-Based Model Predicts Adverse Outcomes in Patients With Coronary Artery DiseaseShivang R Desai, Devinder S Dhindsa, Yi-An Ko, et al.
JAMA Cardiology|August 10, 2018
Association of Interleukin 6 Receptor Variant With Cardiovascular Disease Effects of Interleukin 6 Receptor Blocking Therapy: A Phenome-Wide Association StudyTianxi Cai, Yichi Zhang, Yuk-Lam Ho, et al.
BMJ Quality & Safety|October 5, 2025
Understanding factors influencing sustainability and sustainment of evidence-based bronchiolitis management of infants in Australian and New Zealand hospital settings: a qualitative process evaluationVictoria Ramsden, Franz E Babl, Libby Haskell, et al.
Plos One|October 11, 2012
qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profilesSarah Song, Katia Nones, David Miller, et al.
Pageof 22